MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 12, 2016, Pages 2881-2891

  Chen, Weishen ^a   Chen, Lingwu ^a   Zhang, Ziji ^a   Meng, Fangang ^a   Huang, Guangxin ^a   Sheng, Puyi ^a   Zhang, Zhiqi ^a   Liao, Weiming ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cartilage specific genes; Chondrogenesis; Class I HDACs; Histone acetylation; miR 455 3p

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE 3; GLYCOSAMINOGLYCAN; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 8; HISTONE H3; INTERLEUKIN 9; MICRORNA; MICRORNA 455 3P; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TRICHOSTATIN A; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; COL2A1 PROTEIN, HUMAN; HDAC2 PROTEIN, HUMAN; HDAC8 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; INTERLEUKIN 1; MIRN455 MICRORNA, HUMAN; MIRN455 MICRORNA, MOUSE; MMP13 PROTEIN, HUMAN; REPRESSOR PROTEIN; RUNX2 PROTEIN, MOUSE; SOX9 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; STAINING; UPREGULATION; WESTERN BLOTTING; ACETYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BINDING SITE; CARTILAGE; CHONDROCYTE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PRIMARY CELL CULTURE; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ACETYLATION; ANIMALS; BASE SEQUENCE; BINDING SITES; CARTILAGE; CELL LINE, TUMOR; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 13; MICE; MICRORNAS; PRIMARY CELL CULTURE; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR;

EID: 84988354869     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2016.09.010     Document Type: Article

References (38)

1. [1] Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.P., Fahmi, H., Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7 (2011), 33–42.
2. [2] Sandell, L.J., Etiology of osteoarthritis: genetics and synovial joint development. Nat. Rev. Rheumatol. 8 (2012), 77–89.
3. [3] Lefebvre, V., Smits, P., Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res. C Embryo Today 75 (2005), 200–212.
4. [4] Furumatsu, T., Tsuda, M., Yoshida, K., Taniguchi, N., Ito, T., Hashimoto, M., Ito, T., Asahara, H., Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J. Biol. Chem. 280 (2005), 35203–35208.
5. [5] Bell, D.M., Leung, K.K., Wheatley, S.C., Ng, L.J., Zhou, S., Ling, K.W., Sham, M.H., Koopman, P., Tam, P.P., Cheah, K.S., SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16 (1997), 174–178.
6. [6] Bi, W., Deng, J.M., Zhang, Z., Behringer, R.R., de Crombrugghe, B., Sox9 is required for cartilage formation. Nat. Genet. 22 (1999), 85–89.
7. [7] Ruijter, A.J.M.d., Gennip, A.H.v., Caron, H.N., Kemp, S., Kuilenburg, A.B.P.v., Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370 (2003), 737–749.
8. [8] Vega, R.B., Matsuda, K., Oh, J., Barbosa, A.C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J.M., Richardson, J.A., Karsenty, G., Olson, E.N., Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119 (2004), 555–566.
9. [9] Wuelling, M., Vortkamp, A., Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification. Pediatr. Nephrol. 25 (2010), 625–631.
10. [10] Hong, S., Derfoul, A., Pereira-Mouries, L., Hall, D.J., A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 23 (2009), 3539–3552.
11. [11] Culley, K.L., Hui, W., Barter, M.J., Davidson, R.K., Swingler, T.E., Destrument, A.P., Scott, J.L., Donell, S.T., Fenwick, S., Rowan, A.D., Young, D.A., Clark, I.M., Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. Arthritis Rheum. 65 (2013), 1822–1830.
12. [12] Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
13. [13] Zhang, Z., Kang, Y., Zhang, Z., Zhang, H., Duan, X., Liu, J., Li, X., Liao, W., Expression of microRNAs during chondrogenesis of human adipose-derived stem cells. Osteoarthr. Cartil. 20 (2012), 1638–1646.
14. [14] Meng, F., Zhang, Z., Chen, W., Huang, G., He, A., Hou, C., Long, Y., Yang, Z., Zhang, Z., Liao, W., MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1beta-induced chondrocyte responses. Osteoarthr. Cartil. 24 (2016), 932–941.
15. [15] Zhang, Z., Hou, C., Meng, F., Zhao, X., Zhang, Z., Huang, G., Chen, W., Fu, M., Liao, W., MiR-455-3p regulates early chondrogenic differentiation via inhibiting Runx2. FEBS Lett. 589 (2015), 3671–3678.
16. [16] Hou, C., Meng, F., Zhang, Z., Kang, Y., Chen, W., Huang, G., Fu, M., Sheng, P., Zhang, Z., Liao, W., The role of MicroRNA-381 in chondrogenesis and interleukin-1-beta induced chondrocyte responses. Cell. Physiol. Biochem. 36 (2015), 1753–1766.
17. [17] Swingler, T.E., Wheeler, G., Carmont, V., Elliott, H.R., Barter, M.J., Abu-Elmagd, M., Donell, S.T., Boot-Handford, R.P., Hajihosseini, M.K., Munsterberg, A., Dalmay, T., Young, D.A., Clark, I.M., The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum. 64 (2012), 1909–1919.
18. [18] Palmer, G., Guicheux, J., Bonjour, J.P., Caverzasio, J., Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology 141 (2000), 2236–2243.
19. [19] Lago, R., Gomez, R., Otero, M., Lago, F., Gallego, R., Dieguez, C., Gomez-Reino, J.J., Gualillo, O., A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthr. Cartil. 16 (2008), 1101–1109.
20. [20] Gosset, M., Berenbaum, F., Thirion, S., Jacques, C., Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3 (2008), 1253–1260.
21. [21] Oppenheimer, H., Kumar, A., Meir, H., Schwartz, I., Zini, A., Haze, A., Kandel, L., Mattan, Y., Liebergall, M., Dvir-Ginzberg, M., Set7/9 impacts COL2A1 expression through binding and repression of SirT1 histone deacetylation. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 29 (2014), 348–360.
22. [22] Nakajima, A., Shimizu, S., Moriya, H., Yamazaki, M., Expression of fibroblast growth factor receptor-3 (FGFR3), signal transducer and activator of transcription-1, and cyclin-dependent kinase inhibitor p21 during endochondral ossification: differential role of FGFR3 in skeletal development and fracture repair. Endocrinology 144 (2003), 4659–4668.
23. [23] Kim, K.S., Choi, H.W., Yoon, H.E., Kim, I.Y., Reactive oxygen species generated by NADPH oxidase 2 and 4 are required for chondrogenic differentiation. J. Biol. Chem. 285 (2010), 40294–40302.
24. [24] Nakamura, Y., Yamamoto, K., He, X., Otsuki, B., Kim, Y., Murao, H., Soeda, T., Tsumaki, N., Deng, J.M., Zhang, Z., Behringer, R.R., Crombrugghe, B., Postlethwait, J.H., Warman, M.L., Nakamura, T., Akiyama, H., Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat. Commun., 2, 2011, 251.
25. [25] Hou, C., Yang, Z., Kang, Y., Zhang, Z., Fu, M., He, A., Zhang, Z., Liao, W., MiR-193b regulates early chondrogenesis by inhibiting the TGF-beta2 signaling pathway. FEBS Lett. 589 (2015), 1040–1047.
26. [26] Zhang, P., Jimenez, S.A., Stokes, D.G., Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J. Biol. Chem. 278 (2003), 117–123.
27. [27] Liu, Y., Li, H., Tanaka, K., Tsumaki, N., Yamada, Y., Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J. Biol. Chem. 275 (2000), 12712–12718.
28. [28] Sekiya, I., Tsuji, K., Koopman, P., Watanabe, H., Yamada, Y., Shinomiya, K., Nifuji, A., Noda, M., SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 275 (2000), 10738–10744.
29. [29] Van Lint, C., Emiliani, S., Verdin, E., The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5 (1996), 245–253.
30. [30] Peart, M.J., Smyth, G.K., van Laar, R.K., Bowtell, D.D., Richon, V.M., Marks, P.A., Holloway, A.J., Johnstone, R.W., Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 3697–3702.
31. [31] Whetstine, J.R., Ceron, J., Ladd, B., Dufourcq, P., Reinke, V., Shi, Y., Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase. Mol. Cell 18 (2005), 483–490.
32. [32] Guan, Y.J., Yang, X., Wei, L., Chen, Q., MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J. 25 (2011), 4457–4466.
33. [33] Li, Z., Hassan, M.Q., Jafferji, M., Aqeilan, R.I., Garzon, R., Croce, C.M., van Wijnen, A.J., Stein, J.L., Stein, G.S., Lian, J.B., Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem. 284 (2009), 15676–15684.
34. [34] Song, J., Jin, E.H., Kim, D., Kim, K.Y., Chun, C.H., Jin, E.J., MicroRNA-222 regulates MMP-13 via targeting HDAC-4 during osteoarthritis pathogenesis. BBA Clin. 3 (2015), 79–89.
35. [35] Young, D.A., Lakey, R.L., Pennington, C.J., Jones, D., Kevorkian, L., Edwards, D.R., Cawston, T.E., Clark, I.M., Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res. Ther. 7 (2005), R503–R512.
36. [36] Chabane, N., Zayed, N., Afif, H., Mfuna-Endam, L., Benderdour, M., Boileau, C., Martel-Pelletier, J., Pelletier, J.P., Duval, N., Fahmi, H., Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthr. Cartil. 16 (2008), 1267–1274.
37. [37] Saito, T., Nishida, K., Furumatsu, T., Yoshida, A., Ozawa, M., Ozaki, T., Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 through the inhibition of the MAPK signaling pathway in cultured human chondrocytes. Osteoarthr. Cartil. 21 (2013), 165–174.
38. [38] Chen, W.P., Bao, J.P., Hu, P.F., Feng, J., Wu, L.D., Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. Mol. Biol. Rep. 37 (2010), 3967–3972.